XML 19 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenue and Other Income      
Gross earned premiums $ 135,401 $ 123,050 $ 106,614
Ceded earned premiums (38,690) (24,248) (17,511)
Net earned premiums 96,711 98,802 89,103
Net investment income 3,043 1,968 3,156
Net realized investment gains (losses) (1,505) 2,878 8,126
Change in fair value of equity securities 403 (2,020) 228
Gain from VSRM Transaction 8,810 0 0
Loss portfolio transfer risk fee (5,400) 0 0
Other gains (losses) 59 11,664 260
Other income 2,768 2,671 2,615
Total revenue and other income 104,889 115,963 103,488
Expenses      
Losses and loss adjustment expenses, net 81,440 69,861 56,228
Policy acquisition costs 22,179 28,451 26,105
Operating expenses 18,789 16,509 18,468
Interest expense 2,971 2,852 2,925
Total expenses 125,379 117,673 103,726
Income (loss) before income taxes (20,490) (1,710) (238)
Equity earnings in Affiliate, net of tax 368 824 839
Income tax expense (benefit) (9,441) 208 6
Net income (loss) $ (10,681) $ (1,094) $ 595
Net income (loss) per share, basic $ (1.00) $ (0.11) $ 0.06
Net income (loss) per share, diluted $ (1.00) $ (0.11) $ 0.06
Weighted average common shares outstanding, basic [1] 10,692,090 9,691,998 9,625,059
Weighted average common shares outstanding, diluted [1] 10,692,090 9,691,998 9,625,059
[1] The non-vested shares of the restricted stock units and stock options were anti-dilutive as of December 31, 2022, 2021, and 2020. Therefore, the non-vested shares are excluded from earnings (loss) per share for the years ended December 31, 2022, 2021, and 2020.